Cargando…

Recent advances in multiple myeloma: a Korean perspective

Epidemiologically, multiple myeloma (MM) is a malignant disorder of plasma cells with a higher incidence among Western populations than among Asians. However, there is growing evidence of a recent increase in the age-standardized incidence rate (ASR) of MM in Asian countries, particularly Korea. App...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Junshik, Lee, Jae Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016289/ https://www.ncbi.nlm.nih.gov/pubmed/27604794 http://dx.doi.org/10.3904/kjim.2015.408

Ejemplares similares

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
por: Kim, Seok Jin, et al.
Publicado: (2016)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

Recent Advances in the Treatment of Patients with Multiple Myeloma
por: Legarda, Mario A., et al.
Publicado: (2020)

Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
por: Abramson, Hanley N.
Publicado: (2023)

Recent advances in the treatment of multiple myeloma: a brief review
por: Bobin, Arthur, et al.
Publicado: (2022)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
por: Martino, Massimo, et al.
Publicado: (2021)

Recent Advances on the Pathobiology and Treatment of Multiple Myeloma
por: Amodio, Nicola
Publicado: (2021)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

Recent advances in the management of older adults with newly diagnosed multiple myeloma in Japan
por: Suzuki, Tomotaka, et al.
Publicado: (2022)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Consolidation in multiple myeloma – current status and perspectives
por: Olszewska-Szopa, Magdalena, et al.
Publicado: (2014)

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
por: Bruno, Benedetto, et al.
Publicado: (2021)

Advances in the treatment of extramedullary disease in multiple myeloma
por: Li, Yating, et al.
Publicado: (2022)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
por: Chavez, Julio C., et al.
Publicado: (2022)

Mouse models of multiple myeloma: technologic platforms and perspectives
por: Rossi, Marco, et al.
Publicado: (2018)

Recent Advances in the Pathogenesis and Management of Cast Nephropathy (Myeloma Kidney)
por: Stringer, Stephanie, et al.
Publicado: (2011)

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
por: Jung, Sung-Hoon, et al.
Publicado: (2022)

Cellular immunotherapy in multiple myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2019)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Advanced Imaging in Multiple Myeloma: New Frontiers for MRI
por: Torkian, Pooya, et al.
Publicado: (2022)

Frontline therapy for newly diagnosed patients with multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2020)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
por: Liu, Cheng-Der, et al.
Publicado: (2020)

Recent Advances and Future Perspectives on Microfluidic Liquid Handling
por: Nguyen, Nam-Trung, et al.
Publicado: (2017)

Proteasome inhibitors – molecular basis and current perspectives in multiple myeloma
por: Kubiczkova, Lenka, et al.
Publicado: (2014)

Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives
por: Saltarella, Ilaria, et al.
Publicado: (2022)

Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022)

Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies
por: Lee, Eunyoung, et al.
Publicado: (2021)

Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies
por: Wang, Xi, et al.
Publicado: (2021)

Therapeutic Advancements in Multiple Myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2014)

Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
por: Taiana, Elisa, et al.
Publicado: (2021)

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
por: Micallef, Johann, et al.
Publicado: (2010)

Tumor-associated macrophages in multiple myeloma: advances in biology and therapy
por: Sun, Jennifer, et al.
Publicado: (2022)

Recent advances in the treatment of multiple sclerosis
por: Bennett, Jeffrey L, et al.
Publicado: (2010)

Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019)

Medulloblastoma: Current Perspectives and Recent Advances
por: Choi, Jung Yoon
Publicado: (2023)

Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article
por: Hussain, Munawwar, et al.
Publicado: (2023)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jue463r7u7ap9og6bajcrs6ggr